[go: up one dir, main page]

ES2109493T3 - Forma galenica para administracion ocular y procedimiento de preparacion. - Google Patents

Forma galenica para administracion ocular y procedimiento de preparacion.

Info

Publication number
ES2109493T3
ES2109493T3 ES93910086T ES93910086T ES2109493T3 ES 2109493 T3 ES2109493 T3 ES 2109493T3 ES 93910086 T ES93910086 T ES 93910086T ES 93910086 T ES93910086 T ES 93910086T ES 2109493 T3 ES2109493 T3 ES 2109493T3
Authority
ES
Spain
Prior art keywords
preparation procedure
gallenic
eye administration
gallenic form
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93910086T
Other languages
English (en)
Inventor
Jean-Marc Aiache
Gilbert Serpin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9429535&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2109493(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2109493T3 publication Critical patent/ES2109493T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE A UNA FORMA GALENICA DESTINADA A LA ADMINISTRACION OCULAR, CARACTERIZADO PORQUE COMPRENDE, DEL INTERIOR HACIA EL EXTERIOR: UNA MATRIZ, CONSTITUIDA DE AL MENOS UN POLIMERO, QUE CONTIENE AL MENOS UN PRINCIPIO ACTIVO; UNA PRIMERA CAPA DE GLICERIDOS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION DE TAL FORMA GALENICA.
ES93910086T 1992-05-05 1993-05-05 Forma galenica para administracion ocular y procedimiento de preparacion. Expired - Lifetime ES2109493T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9205514A FR2690846B1 (fr) 1992-05-05 1992-05-05 Forme galenique pour administration oculaire et procede de preparation.

Publications (1)

Publication Number Publication Date
ES2109493T3 true ES2109493T3 (es) 1998-01-16

Family

ID=9429535

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93910086T Expired - Lifetime ES2109493T3 (es) 1992-05-05 1993-05-05 Forma galenica para administracion ocular y procedimiento de preparacion.

Country Status (8)

Country Link
US (1) US5766619A (es)
EP (1) EP0639069B1 (es)
JP (1) JP3208568B2 (es)
KR (1) KR100206481B1 (es)
DE (1) DE69314950T2 (es)
ES (1) ES2109493T3 (es)
FR (1) FR2690846B1 (es)
WO (1) WO1993021901A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
JP2002534139A (ja) * 1999-01-05 2002-10-15 マサチューセッツ・アイ・アンド・イア・インファーマリー 網膜と脈絡膜への経強膜徐放性薬剤標的送達
US6413245B1 (en) 1999-10-21 2002-07-02 Alcon Universal Ltd. Sub-tenon drug delivery
TR200201047T2 (tr) 1999-10-21 2002-07-22 Alcon, Inc. İlaç verme vasıtası.
US6416777B1 (en) 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
US7943162B2 (en) * 1999-10-21 2011-05-17 Alcon, Inc. Drug delivery device
EP1387671A1 (en) 2001-05-03 2004-02-11 MASSACHUSETTS EYE & EAR INFIRMARY Implantable drug delivery device and use thereof
BR0210494A (pt) 2001-07-23 2004-06-22 Alcon Inc Dispositivo de administração de droga oftálmica
BR0210287A (pt) * 2001-07-23 2005-12-13 Alcon Inc Dispositivo de administração de droga oftalmológica
AU2003217531A1 (en) * 2002-05-02 2003-11-17 Massachusetts Eye And Ear Infirmary Ocular drug delivery systems and use thereof
WO2004073551A2 (en) * 2003-02-18 2004-09-02 Massachusetts Eye And Ear Infirmary Transscleral drug delivery device and related methods
AU2004274026A1 (en) * 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
JP2008530127A (ja) 2005-02-09 2008-08-07 マクサイト， インコーポレイテッド 眼の処置のための処方物
US8663639B2 (en) * 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
JP2009502954A (ja) 2005-07-27 2009-01-29 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド タンパク質のミスフォールディングを修正する小分子及びその使用
CA2617040A1 (en) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. Non-invasive drug delivery system targeting posterior eye tissue using solid composition
DK1968594T3 (da) 2005-11-29 2010-12-13 Glaxosmithkline Llc Behandling af okulære neovaskulære lidelser, såsom makulær degeneration, striae angioides og makulært ødem
WO2007092620A2 (en) 2006-02-09 2007-08-16 Macusight, Inc. Stable formulations, and methods of their preparation and use
AU2007230964B2 (en) * 2006-03-23 2012-07-19 Santen Pharmaceutical Co., Ltd. Formulations and methods for vascular permeability-related diseases or conditions
US20080265343A1 (en) * 2007-04-26 2008-10-30 International Business Machines Corporation Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
US8632511B2 (en) 2009-05-06 2014-01-21 Alcon Research, Ltd. Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
IN2012DN00352A (es) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
US20120232102A1 (en) 2009-09-30 2012-09-13 Chun-Fang Xu Methods Of Administration And Treatment
US8177747B2 (en) 2009-12-22 2012-05-15 Alcon Research, Ltd. Method and apparatus for drug delivery
CA2838974A1 (en) 2011-06-14 2012-12-20 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
WO2013058809A1 (en) 2011-10-19 2013-04-25 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
WO2013082000A1 (en) 2011-11-30 2013-06-06 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
CA2862746A1 (en) 2011-12-01 2013-06-06 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
CN109549922B (zh) * 2018-12-27 2021-04-20 湖北远大天天明制药有限公司 一种托吡卡胺眼用组合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3630200A (en) * 1969-06-09 1971-12-28 Alza Corp Ocular insert
SE352811B (es) * 1971-06-04 1973-01-15 Pharmacia Ab
US3986510A (en) * 1971-09-09 1976-10-19 Alza Corporation Bioerodible ocular device
US3828777A (en) * 1971-11-08 1974-08-13 Alza Corp Microporous ocular device

Also Published As

Publication number Publication date
EP0639069B1 (fr) 1997-10-29
DE69314950D1 (de) 1997-12-04
DE69314950T2 (de) 1998-04-16
FR2690846B1 (fr) 1995-07-07
KR100206481B1 (en) 1999-07-01
FR2690846A1 (fr) 1993-11-12
KR950701214A (ko) 1995-03-23
US5766619A (en) 1998-06-16
EP0639069A1 (fr) 1995-02-22
JP3208568B2 (ja) 2001-09-17
WO1993021901A1 (fr) 1993-11-11
JPH07506356A (ja) 1995-07-13

Similar Documents

Publication Publication Date Title
ES2109493T3 (es) Forma galenica para administracion ocular y procedimiento de preparacion.
ES2159591T3 (es) Composicion de liberacion controlada.
ES2107235T3 (es) Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
ES2166781T3 (es) Preparados farmaceuticos para el tratamiento selectivo de la enfermedad de crohn y colitis ulcerosa.
ECSP034455A (es) Forma de dosificacion de farmaco activada por hidrogel
AR039132A2 (es) Metodo para administrar un agente farmaceuticamente activo al ojo teniendo dicho ojo una esclerotica, una capsula de tenon y una macula
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
ES2130217T3 (es) Uso de tiloxapol como dispersante y estabilizante de nanoparticulas.
GT199900203A (es) Composiciones de celecoxib.
AR027066A1 (es) Forma de dosificacion de farmaco en capas impulsada por hidrogel
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
CO5251434A1 (es) Composicion de liberacion controlada
ES2185654T3 (es) Sistema para la administracion de farmacos.
ES2188787T3 (es) Compuesto medicamentoso de micela copolimera y metodo para su preparacion.
CO4600739A1 (es) Formulaciones liquidas orales a base de alendronato
MX9603064A (es) Copolimeros biodegradables y articulos de plastico que comprenden copolimeros biodegradables de 3-hidroxilohexanoato.
ES2145653B1 (es) Procedimiento y dispositivo para la fabricacion de cuerpos huecos en forma de t, o bien que presentan al menos una desviacion en forma de domo.
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
BR0012696A (pt) Composição oftálmica
GT199100051A (es) Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales
PE17397A1 (es) Compuesto trans-dermico en parche del 3-[4-(hexiloxi)-1,2,5-tiadiazol-3-il]-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina)
ES2130446T3 (es) Sistema terapeutico transdermico que contiene octildodecanol como inhibidor de cristalizacion.
ES2152016T3 (es) Solucion oftalmica de pranoprofeno conteniendo amina organica.
AR002743A1 (es) Esmalte de unas, y la utilizacion de dicho esmalte para la preparacion de un medicamento para el tratamiento de onicomicosis.
AR032642A1 (es) Composiciones quimioterapicas de paclitaxel en microemulsion con mayor biodisponibilidad oral.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 639069

Country of ref document: ES